UBS Group AG Grows Stock Holdings in National Health Investors, Inc. $NHI

UBS Group AG raised its position in shares of National Health Investors, Inc. (NYSE:NHI) by 3.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 197,518 shares of the real estate investment trust’s stock after purchasing an additional 6,984 shares during the period. UBS Group AG owned approximately 0.41% of National Health Investors worth $15,084,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. TBH Global Asset Management LLC grew its stake in shares of National Health Investors by 17.8% during the fourth quarter. TBH Global Asset Management LLC now owns 17,236 shares of the real estate investment trust’s stock valued at $1,316,000 after buying an additional 2,599 shares during the last quarter. M&T Bank Corp bought a new position in shares of National Health Investors during the fourth quarter valued at about $2,996,000. OVERSEA CHINESE BANKING Corp Ltd grew its stake in shares of National Health Investors by 59.8% during the fourth quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 53,168 shares of the real estate investment trust’s stock valued at $4,060,000 after buying an additional 19,892 shares during the last quarter. Meritage Portfolio Management grew its stake in shares of National Health Investors by 47.6% during the fourth quarter. Meritage Portfolio Management now owns 62,512 shares of the real estate investment trust’s stock valued at $4,774,000 after buying an additional 20,172 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of National Health Investors by 2.9% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 27,737 shares of the real estate investment trust’s stock valued at $2,118,000 after buying an additional 775 shares during the last quarter. 62.51% of the stock is owned by institutional investors.

National Health Investors Stock Up 0.8%

NYSE NHI opened at $74.99 on Thursday. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20. The stock has a market capitalization of $3.63 billion, a PE ratio of 24.19, a PEG ratio of 4.27 and a beta of 0.55. National Health Investors, Inc. has a 1 year low of $68.80 and a 1 year high of $91.38. The business’s 50-day moving average is $81.90 and its 200 day moving average is $80.53.

National Health Investors (NYSE:NHI) last posted its earnings results on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.21 by ($0.39). The business had revenue of $115.13 million during the quarter, compared to the consensus estimate of $70.22 million. National Health Investors had a return on equity of 9.82% and a net margin of 36.86%.The firm’s revenue for the quarter was up 28.9% compared to the same quarter last year. During the same period in the previous year, the business earned $1.15 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Sell-side analysts forecast that National Health Investors, Inc. will post 4.76 earnings per share for the current year.

National Health Investors Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Tuesday, June 30th will be paid a $0.92 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.68 annualized dividend and a dividend yield of 4.9%. National Health Investors’s dividend payout ratio (DPR) is presently 118.71%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on NHI shares. Wells Fargo & Company reduced their price objective on National Health Investors from $86.00 to $84.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 22nd. National Bank Financial set a $85.00 price objective on National Health Investors in a research note on Tuesday, January 20th. Truist Financial reduced their price objective on National Health Investors from $92.00 to $89.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of National Health Investors in a research note on Friday, March 27th. Finally, Deutsche Bank Aktiengesellschaft cut National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price objective on the stock. in a research note on Tuesday, January 20th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $87.50.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.